Study to Investigate the Effects of AZD6140 in Patients With Renal Impairment and in Healthy Volunteers.

Trial Profile

Study to Investigate the Effects of AZD6140 in Patients With Renal Impairment and in Healthy Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 02 Dec 2010

At a glance

  • Drugs Ticagrelor (Primary)
  • Indications Cardiovascular disorders; Thrombosis
  • Focus Pharmacokinetics
  • Most Recent Events

    • 02 Oct 2008 Status changed from recruiting to completed, based on information from ClinicalTrials.gov.
    • 06 Sep 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top